Skip to content

Randomized Controlled Trial on the Effects of Yiqi Fumai Keli on Recurrence in Patients with Atrial Fibrillation after Radiofrequency Ablation

Randomized Controlled Trial on the Effects of Yiqi Fumai Keli on Recurrence in Patients with Atrial Fibrillation after Radiofrequency Ablation

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038655
Enrollment
Unknown
Registered
2020-09-27
Start date
2020-10-09
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Sponsors

Dongfang Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The patients met the diagnostic criteria of atrial fibrillation and underwent radiofrequency ablation successfully; (2) TCM syndrome differentiation is in accordance with Qi deficiency and blood stasis, phlegm heat disturbing heart syndrome; (3) Aged 18-80 years old; (4) Volunteer to participate and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Severe structural heart disease, heart failure (LVEF <=40%), serious arrhythmia such as persistent ventricular tachycardia; (2) Thyroid disease, severe liver and kidney disease, mental illness and malignant tumor, pregnant women and breast-feeding; (3) Participants in other clinical trials within 3 months; (4) Patients who used other antiarrhythmic Chinese patent medicines and their preparations.

Design outcomes

Primary

MeasureTime frame
Recurrence rate of atrial fibrillation;

Secondary

MeasureTime frame
TCM Syndrome Evaluation;

Countries

China

Contacts

Public ContactJiqiang Hu

Department of Cardiology, Dongfang Hospital, Beijing University of Chinese Medicine

hujiqiang0923@163.com+86 13522675198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026